^{Cell Therapy, Tissue Science and Regenerative Medicine}

Biography

Through his dual roles as Vice President for University Partnerships at the Maryland Technology Development Corporation (TEDCO) and Executive Director of the Maryland Stem Cell Research Fund, Dr. Gincel oversees programs on university research, tech transfer, and commercialization and innovation that contribute to economic growth in Maryland. He is dedicated to increasing research capacity for Maryland scientists, supporting cutting-edge technology development, and ultimately, developing cures for debilitating diseases. Recently Dr. Gincel launched a new initiative called Accelerating Cures to support regenerative medicine and cell therapy technologies moving from research to commercialization and finally to clinical trials. Accelerating Cure has five programs to address the different stages the cell therapy technologies to go through. Dr. Gincel received his Bachelor of Science and Doctor of Philosophy (Biochemistry and Neuroscience) from the Ben-Gurion University (Israel).

Research Interest

Accelerating Cures to support regenerative medicine and cell therapy technologies